Patent Yard Sign in
European application, no grantEurope

Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors

EP 0871475 A2 · Applicant: BRISTOL-MYERS SQUIBB COMPANY

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed September 12, 1996 and never granted as a European patent. Had it been granted, its 20-year term would have ended September 12, 2016.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by March 12, 2022.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledSeptember 12, 1996
PublishedOctober 21, 1998
GrantedNever granted
Term endedSeptember 12, 2016
Application numberEP 96930842
Classification (CPC)A61P43/00 +2 more

Timeline

Timeline From EPO dates

1997199920012003200520072009201120132015Application filedSep 12, 1996PublishedOct 21, 1998Term endedSep 12, 2016

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.